- New Publication: Performance of the Percepta GSC as a complement to bronchoscopy for indeterminate lung nodules
PATIENTS & CAREGIVERS
What is the Percepta Genomic Sequencing Classifier?
A genomic test that can help guide next steps when bronchoscopy is not conclusive
During your bronchoscopy procedure, your doctor collects cells from your airway using a small brush. In the event your bronchoscopy doesn’t show a definite result, your doctor may order a test called the Percepta® Genomic Sequencing Classifier (GSC), which analyzes these cells to determine your risk of lung cancer.
How can we help?
Veracyte representatives are happy to assist you. Monday-Friday, 5:30AM - 5PM (Pacific Time)
Client services
+1.844.464.5864 Office
+1.650.243.6335 Fax
Support email
support@veracyte.com
The Percepta Genomic Sequencing Classifier (GSC) is available in the US as part of Veracyte’s CLIA-validated laboratory developed test (LDT) service. This test has not been cleared or approved by the FDA.
This website contains information on products that are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for you accessing such information that may not comply with any legal process, regulation, registration or usage in the country of your origin.
© 2023 Veracyte, Inc. All rights reserved.
Offices
6000 Shoreline Court, Suite 300
South San Francisco, CA 94080
163 Avenue de Luminy
13009 Marseille
FRANCE
6925 Lusk Boulevard, Suite 200
San Diego, CA 92121
12357-A Riata Trace Parkway
Building 5, Suite 100
Austin, TX 78727
Connect